Strategy News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 14 articles
Danuglipron Phase 3 Watch After Pfizer’s Phase 2b Obesity Win
Puma Biotechnology Inducement Awards: Strategic Talent Moves Under Nasdaq Rule 5635(c)(4)
Facet Life Sciences Appoints Frank Closurdo as VP, Commercial Services
Senior NIH official pushes MAHA strategy to skeptical ADA audience
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
Physician-Led Patient Education: A Strategy to Mitigate the Gross-to-Net Squeeze
FDA Expands ENDS Market Access: Implications for Pharma BD and Investors
CMS Finalizes Medicaid Work Requirement Rules, Impacting State Programs and Pharma Strategy
Pharma Partnering US: $77.3B Licensing Deals in Q1 2026
Novartis Reports Strong Q1 2026 Growth Led by Remibrutinib CHMP Approval and Pipeline Advances
Pharma Compliance Congress: Key Regulatory Updates Day 1
Oncology Data Landscape 2026: Key Trends & Upcoming Readouts